FDA Warns About GMP Violations, False Drug Advertising
23 May 2025 //
RAPS
Sarfez Pharma Recieves Warning Letter
20 May 2025 //
FDA
Novo Integrated Sciences’ Subsidiary, Signs Agreement with Sarfez Pharma
30 Nov 2022 //
BUSINESSWIRE
23 May 2025 //
RAPS
20 May 2025 //
FDA
30 Nov 2022 //
BUSINESSWIRE